Bees, fire ants and vespids cause insect sting allergy. These insects have unique as well as common venom allergens. Vespids, including hornets, paper wasps and yellow jackets, have common allergens. Bees and vespids have one common allergen with hyaluronidase activity; they also have unique allergens with different phospholipase activities. Fire ants and vespids have one common allergen, antigen 5 of unknown biologic activity. The common venom allergens with < 70% sequence identity have barely detectable levels of antigenic cross-reactivity. Possible uses of modified allergens for immunotherapy are described.

Keywords:
Stinging insect venom allergens
1.
Guralnick MW, Benton AW: Entomological aspects of insect sting allergy. Milwaukee, American Academy of Allergy and Immunology, 1995, pp 7–20.
2.
Loveless MH, Fackeler WR: Wasp venom allergy and immunity. Ann Allergy 1959;14:347–366.
3.
Lichtenstein LM, Valentine MD, Sobotka AK: Insect allergy: The state of the art. J Allergy Clin Immunol 1979;64:5–12.
4.
King TP, Sobotka AK, Kochoumian L, Lichtenstein LM: Allergens of honeybee venom. Arch Biochem Biophys 1976;172:661–671.
5.
Dudler T, Chen W, Wang S, Schneider T, Annand RR, Dempcy RO, Crameri R, Gmachl M, Suter M, Gelb MH: High-level expression in Escherichia coli and rapid purification of enzymatically active honey bee venom phospholipase A2. Biochim Biophys Acta 1992;1165:201–210.
6.
Scott DL, Otwinowski Z, Gelb MH, Sigler P: Crystal structure of bee venom phospholipase A2 in a complex with a transition-state analogue. Science 1990;250:1563–1566.
7.
Gmachl M, Kreil G: Bee venom hyaluronidase is homologous to a membrane protein of mammalian sperm. Proc Natl Acad Sci USA 1993;90:3569–3573.
8.
Markovi-Housley Z, Schirmer T, Soldatova LN, Mueller UR: A preliminary cystallographic structure of a recombinant bee venom hyaluronidase. J Allergy Clin Immunol 1999;103:S170.
9.
Hoffman DR: Hymenoptera Venom Proteins. New York, Plenum Publishing, 1996, pp 169–186.
10.
Soldatova LN, Bakst JB, Hoffman DR, Slater JE: Molecular cloning of a new honeybee venom allergen, acid phosphatase. J Allergy Clin Immunol 2000;105:S378.
11.
Hoffmann DR, Robert S, Jacobson MS: Allergens in Hymenoptera venom. XXVII. Bumblebee venom allergy and allergens. J Allergy Clin Immunol 1996;97:812–821.
12.
Soldatova L, Kochoumian L, King TP: Sequence similarity of a hornet D. maculata venom allergen phospholipase A1 with mammalian lipases. FEBS Lett 1993;320:145–149.
13.
Lu G, Kochoumian L, King TP: Sequence identity and antigenic cross-reactivity of white face hornet venom allergen, also a hyaluronidase, with other proteins. J Biol Chem 1995;270:4457–4465.
14.
Lu G, Villalba M, Coscia MR, Hoffman DR, King TP: Sequence analysis and antigen cross-reactivity of a venom allergen antigen 5 from hornets, wasps and yellow jackets. J Immunol 1993;150:2823–2830.
15.
Tomalski MD, King TP, Miller LK: Expression of hornet genes encoding venom allergen antigen 5 in insects. Arch Insect Biochem Physiol 1993;22:303–313.
16.
Hoffman DR: Allergens in Hymenoptera venom. XXV. The amino acid sequences of antigen 5 molecules and the structural basis of antigenic cross-reactivity. J Allergy Clin Immunol 1993;92:707–716.
17.
King TP, Lu G, Gonzalez M, Qian NF, Soldatova L: Yellow jacket venom allergens, hyaluronidase and phospholipase: Sequence similarity and antigenic cross-reactivity with their hornet and wasp homologs and possible implications for clinical allergy. J Allergy Clin Immunol 1996;98:588–600.
18.
Monsalve RI, Gang L, King TP: Recombinant venom allergen, antigen 5 of yellow jacket (Vespula vulgaris) and paper wasp (Polistes annularis) by expression in bacteria or yeast. Protein Expr Purif 1999;16:410–416.
19.
Thorsted PB, Holm J, Koed GK, Monsalve RI, King TP, Gajehde M, Spangfort MD: Structural analysis and mapping of IgE epitopes on vespid venom allergen Ves v 5. J Allergy Clin Immunol 2000;105:S330.
20.
Hoffman DR: Allergens in Hymenoptera venom. XXIV. The amino acid sequences of imported fire ant venom allergens Sol i II, Sol i III and Sol i IV. J Allergy Clin Immunol 1995;91:71–78.
21.
Schmidt M, McConnel TJ, Hofmann DR: Production of a recombinant imported fire ant venom allergen, Sol i 2, in native and immunoreactive form. J Allergy Clin Immunol 1996;98:82–88.
22.
Schmidt M, McConnell TJ, Hoffman DR: Expression of recombinant imported fire ant venom allergen Sol i 3. J Allergy Clin Immunol 2000;105:S57.
23.
Larsen JN, Lowenstein H: Allergen nomenclature. J Allergy Clin Immunol 1996;97:577–578.
24.
Hoffman DR, Schmidt JO: Phopholipases from Asian honeybees. J Allergy Clin Immunol 2000;105:S56.
25.
Hoffman DR: Allergens in Hymenoptera venom. XXVI. The complete amino acid sequences of two vespid venom phospholipases. Int Arch Allergy Immunol 1994;104:184–190.
26.
Hoffman DR: Antigen 5 and phospholipase from Polistes dominulus differ significantly in amino acid sequence from those of North American Polistes venoms. J Allergy Clin Immunol 1997;99:S377.
27.
Hoffman DR, Schmidt JO: Amino acid sequences of allergens from Vespa mandarinia, an Asian hornet. J Allergy Clin Immunol 1999;103:S164.
28.
Terwilliger TC, Eisenberg D: The structure of melittin. II. Interpretation of the structure. J Biol Chem 1982;257:6016–6022.
29.
McNairy MM, Gastmeyer J, Pantera B, Hoffman DR: Isolation of paper wasp venom proteases by affinity chromatography. J Allergy Clin Immunol 2000;105:S57.
30.
Abe T, Kasai N, Niwa A: Purification and properties of a presynaptically acting neurotoxin, mandaratoxin, from hornet (Vespa mandarinia). Biochemistry 1982;21:1693–1697.
31.
Withers Martinez C, Carriere F, Verger R, Bourgeois D, Cambillau C: A pancreatic lipase with a phospholipase A1 activity: Crystal structure of a chimeric PLRP2 from guinea pig. Structure 1996;4:1363–1374.
32.
Mizuki N, Kasahara M: Mouse submandibular glands express an androgen-regulated transcript encoding an acidic epididymal glycoprotein-like molecule. Mol Cell Endocrinol 1992;89:25–32.
33.
Murphy EV, Zhang Y, Zhu W, Biggs J: The human glioma pathogenesis-related protein is structurally related to plant pathogenesis-related proteins and its gene is expressed specifically in brain tumors. Gene 1995;159:131–135.
34.
Kjeldsen L, Cowland JB, Johnsen A, Borregarrd N: SGP28, a novel matrix glycoprotein in specific granules of human neutrophils with similarity to a human testis specific gene product and to a rodent sperm coating glycoprotein. FEBS Lett 1996;380:246–250.
35.
Van Loon LC, Van Strien EA: The families of pathogenesis-related proteins, their activities, and comparative analysis of PR-1 type proteins. Physiol Mol Plant Pathol 1999;55:85–97.
36.
Hawdon JM, Jones BF, Hoffmann DR, Hotez PJ: Cloning and characterization of ancylostoma-secreted protein. J Biol Chem 1996;271:6672–6678.
37.
Morrissette J, Kratzschmar J, Haendler B, El-Hayek R, Mochca-Morales J, Martin BM, Patel JR, Moss RL, Schleuning W, Coronado R, Possani LD: Primary structure and properties of helothermine, a peptide toxin that blocks ryanodine receptors. Biophys J 1995;68:2280–2288.
38.
Megraw T, Kaufman TC, Kovalick GE: Sequence and expression of Drosophila antigen 5-related 2, a new member of the CAP gene family. Gene 1998;222:297–304.
39.
Soldatova LN, Crameri R, Gmachl M, Kemeny DM, Schmidt M, Weber M, Mueller UR: Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli. J Allergy Clin Immunol 1998;101:691–698.
40.
Hoffman DR, Miller JS, Sutton JL: Hymenoptera venom allergy: A geographic study. Ann Allergy 1980;45:276–279.
41.
King TP, Kochoumian L, Lu G: Murine T and B cell responses to natural and recombinant hornet venom allergen, Dol m 5.02 and its recombinant fragments. J Immunol 1995;154:577–584.
42.
Schneider T, Lang AB, Carballido JM, Santamaria Babi LF, Dudler T, Kaegi MK, Blaser K, Suter M: Human monoclonal or polyclonal antibodies recognize predominantly discontinuous epitopes on bee venom phospholipase A2. J Allergy Clin Immunol 1994;94:61–70.
43.
Chothia C, Lesk AM: The relation between the divergence of sequence and structure in proteins. EMBO 1986;5:823–826.
44.
Barlow DJ, Edwards MS, Thorton JM: Continuous and discontinuous protein antigenic determinants. Nature 1986;322:747–748.
45.
Mirza O, Henriksen A, Ipsen H, Larsen JN, Wissenbach M, Spangfort MD, Gahjede M: Dominant epitopes and allergic cross-reactivity: Complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1. J Immunol 2000;165:331–338.
46.
King TP, Lu G, Agosto H: Antibody responses to bee melittin (Api m 4) and hornet antigen 5 (Dol m 5) in mice treated with the dominant T-cell epitope peptides. J Allergy Clin Immunol 1998;101:397–403.
47.
King TP, Kochoumian L, Joslyn A: Melittin-specific monoclonal and polyclonal IgE and IgG1 antibodies from mice. J Immunol 1984;133:2668–2673.
48.
Tretter V, Altmann F, Kubelka V, Marz L, Becker WM: Fucose alpha 1,3-linked to the core region of glycoprotein N-glycans creates an important epitope for IgE from honeybee venom allergic individuals. Int Arch Allergy Immunol 1993;102:259–266.
49.
Dhillon M, Roberts C, Nunn T, Kuo M: Mapping human T cell epitopes on phospholipase A2: The major bee-venom allergen. J Allergy Clin Immunol 1992;90:42–51.
50.
Carballido JM, Carballido-Perrig N, Kagi MK, Meloen MH, Wuthrich B, Heusser CH, Blaser K: T cell epitope specificity in human allergic and non-allergic subjects to bee venom phospholipase A2. J Immunol 1993;150:3582–3591.
51.
Specht C, Kolsch E: The murine (H-2k) T-cell epitopes of bee venom phospholipase A2 lie outside the active site of the enzyme. Int Arch Allergy Immunol 1997;112:226–230.
52.
King TP, Lu G: Hornet venom allergen, Dol m 5; its T cell epitopes in mice and its antigenic cross-reactivity with a mammalian testis protein. J Allergy Clin Immunol 1997;99:630–639.
53.
Dudler T, Altmann F, Carballido JM, Blaser K: Carbohydrate-dependent, HLA class II-restricted, human T cell response to the bee venom allergen phospholipase A2 in allergic patients. Eur J Immunol 1995;25:538–542.
54.
Briner TJ, Kuo M, Keating KM, Rogers BL, Greenstein JL: Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proc Natl Acad Sci USA 1993;90:7608–7612.
55.
Hoyne GF, O’Hehir RE, Wraith DC, Thomas WR, Lamb JR: Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 1993;178:1783–1788.
56.
Muller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, Blaser K: Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell tolerance in bee sting allergic patients. J Allergy Clin Immunol 1998;101:747–754.
57.
Norman PS, Nicodemus CF, Group TACS: Multicenter study of several doses of Allervax Cat peptides in the treatment of cat allergy. J Allergy Clin Immunol 1997;99:127.
58.
Creticos PS, Hebert J, Philip G, Group TARS: Efficacy of Allervax ragweed peptides in the treatment of ragweed-induced allergy. J Allergy Clin Immunol 1997;99:401.
59.
Rolland J, O’Hehir R: Immunotherapy of allergy: Anergy, deletion and immune deviation. Curr Opin Immunol 1998;10:640–645.
60.
Golden DB, Kwiterovich KA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM: Discontinuing venom immunotherapy: Outcome after five years. J Allergy Clin Immunol 1996;97:579–587.
61.
Blaser K, Carballido JM, Faith A, Crameri R, Akdis CA: Determinants and mechanisms of human immune responses to bee venom phospholipase A2. Int Arch Allergy Immunol 1998;117:1–10.
62.
Valenta R, Vrtala S, Focke-Tejkl M, Bugajska-Schretter A, Ball T, Twardosz A, Spitzauer S, Gronlund H, Kraft D: Genetically engineered and synthetic allergen derivatives: Candidates for vaccination against type 1 allergy. Biol Chem 1999;380:815–824.
63.
Akdis CA, Blesken T, Wymann D, Akdis M, Blaser K: Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants. Eur J Immunol 1998;28:914–925.
64.
Norman PS, Ishizaka K, Lichtenstein LM, Adkinson NF: Treatment of ragweed hay fever with urea-denatured antigen E. J Allergy Clin Immunol 1980;66:336–341.
65.
King TP, Kagey-Sobotka A, Jim S, Monsalve RI, Lichtenstein LM, Spangfort MD: Allergenicity of hybrid Ag5s of yellow jacket and paper wasp venoms. Int Arch Allergy Immunol 2001;submitted for publication.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.